These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 6421875)

  • 21. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
    Switzer ME; Gordon HJ; McKee PA
    Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology of factor VIII/von Willebrand Factor.
    Meyer D; McKee PA; Hoyer LW; Zimmerman TS; Gralnick HR
    Thromb Haemost; 1978 Oct; 40(2):245-51. PubMed ID: 310584
    [No Abstract]   [Full Text] [Related]  

  • 24. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that von Willebrand factor is not required for the clotting of plasma in the presence of platelets and kaolin (Hardisty-Hutton test).
    McPherson J; Soberano ME; Macdonald C; Zucker MB
    Thromb Haemost; 1984 Apr; 51(2):272-4. PubMed ID: 6429885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
    Muntean W; Rothwangl HJ
    Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
    Hellings JA; Over J; van Mourik JA
    Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysis.
    Knutson GJ; Fass DN
    Blood; 1982 Mar; 59(3):615-24. PubMed ID: 6800420
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigen.
    Weinstein MJ; Fulcher CA; Chute LE; Zimmerman TS
    Blood; 1983 Nov; 62(5):1114-7. PubMed ID: 6414554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. von Willebrand factor as a regulator of intrinsic factor X activation.
    Koppelman SJ; Koedam JA; van Wijnen M; Stern DM; Nawroth PP; Sixma JJ; Bouma BN
    J Lab Clin Med; 1994 Apr; 123(4):585-93. PubMed ID: 8145007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The identification and functional significance of factor VIII components on normal platelets.
    Flaum MA; Donlon JA; Gralnick HR; Rick ME
    Thromb Res; 1982 May; 26(3):165-75. PubMed ID: 6810495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A monoclonal antibody to factor VIII inhibits von Willebrand factor binding and thrombin cleavage.
    Precup JW; Kline BC; Fass DN
    Blood; 1991 May; 77(9):1929-36. PubMed ID: 1902121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of thrombin on the complex between factor VIII and von Willebrand factor.
    Hamer RJ; Koedam JA; Beeser-Visser NH; Sixma JJ
    Eur J Biochem; 1987 Sep; 167(2):253-9. PubMed ID: 3113951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets.
    Gralnick HR; Williams SB; Morisato DK
    Blood; 1981 Aug; 58(2):387-97. PubMed ID: 6788111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of human thrombin to human factor VIII:RAg.
    Hau L; Firkin BG; Howard MA
    Br J Haematol; 1986 Mar; 62(3):479-85. PubMed ID: 3082349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.